共 16 条
[1]
Johnsson G., Regardh C.G., Clin Pharmacokinetics, 1, pp. 233-263, (1976)
[2]
Rubenfeld S., Silverman V.E., Welch K., Mallette L.E., Kohler P.O., Variable plasma propranolollevels in thyrotoxicosis, N Engl J Med, 300, pp. 353-354, (1979)
[3]
Caro J.F., Besarab A., Propranolol therapy for hyperparathyroidism, Lancet, 1, (1978)
[4]
Yorkston N.J., Zaki S.A., Pitcher D.R., Gruzelier J.H., Hollander D., Sergeant H., Propranolol as an adjunct to the treatment of schizophrenia, Lancet, 2, pp. 575-578, (1977)
[5]
Nies A.S., Shand D.G., Clinical pharmacology of propranolol, Circulation, 52, pp. 6-15, (1975)
[6]
Shand D.G., Drug therapy: Propranolol, N Engl J Med, 293, pp. 280-285, (1975)
[7]
Simon M., Babich-Armstrong M., Propranolol in Serum by High Pressure Liquid Chromatography
[8]
Rl N., Peng G.W., Chion W.L., High pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma, J Chromatogr, 145, pp. 429-436, (1978)
[9]
Mason W.D., Amick E.N., Weddle O.H., Rapid determination of propranolol and 4-hydroxypropranolol in plasma by HPLC, Anal Lett, 10, pp. 515-521, (1977)
[10]
Pritchard J.F., Schneck D.W., Racz W.J., Hayes A.H., Contribution of propranolol metabolites to fluorometric assay of propranolol in human plasma, Clin Biochem, 11, pp. 121-125, (1978)